These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 26544755)
1. Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy. Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M Dig Surg; 2015; 32(6):496-503. PubMed ID: 26544755 [TBL] [Abstract][Full Text] [Related]
2. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation. Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933 [TBL] [Abstract][Full Text] [Related]
3. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Carruthers R; Tho LM; Brown J; Kakumanu S; McCartney E; McDonald AC Colorectal Dis; 2012 Oct; 14(10):e701-7. PubMed ID: 22731833 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Shen J; Zhu Y; Wu W; Zhang L; Ju H; Fan Y; Zhu Y; Luo J; Liu P; Zhou N; Lu K; Zhang N; Li D; Liu L Med Sci Monit; 2017 Jan; 23():315-324. PubMed ID: 28100902 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection. Kubo H; Murakami T; Matsuyama R; Yabushita Y; Tsuchiya N; Sawada Y; Homma Y; Kumamoto T; Endo I World J Surg; 2019 Dec; 43(12):3153-3160. PubMed ID: 31549202 [TBL] [Abstract][Full Text] [Related]
6. Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy. Lino-Silva LS; Salcedo-Hernández RA; Ruiz-García EB; García-Pérez L; Herrera-Gómez Á Med Arch; 2016 Jul; 70(4):256-260. PubMed ID: 27703284 [TBL] [Abstract][Full Text] [Related]
7. A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Krauthamer M; Rouvinov K; Ariad S; Man S; Walfish S; Pinsk I; Sztarker I; Charkovsky T; Lavrenkov K Oncology; 2013; 85(1):27-32. PubMed ID: 23816828 [TBL] [Abstract][Full Text] [Related]
8. [Impact of neutrophil-to-lymphocyte ratio on the prognosis of patients with locally advanced colorectal cancer]. Jiang H; Wang H; Li A; Tang E; Chen Y; Wang A; Deng X; Lin M Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):550-554. PubMed ID: 28534334 [TBL] [Abstract][Full Text] [Related]
9. Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection. Portale G; Cavallin F; Valdegamberi A; Frigo F; Fiscon V J Gastrointest Surg; 2018 Sep; 22(9):1611-1618. PubMed ID: 29687424 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients. Tokuhara K; Ueyama Y; Nakatani K; Yoshioka K; Kon M World J Surg Oncol; 2016 Apr; 14():136. PubMed ID: 27129578 [TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy. Zhang LN; Xiao W; OuYang PY; You K; Zeng ZF; Ding PR; Pan ZZ; Xu RH; Gao YH Tumour Biol; 2015 Sep; 36(10):8213-9. PubMed ID: 25994571 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy. Sung S; Son SH; Park EY; Kay CS PLoS One; 2017; 12(3):e0173955. PubMed ID: 28291841 [TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery. Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable? Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935 [TBL] [Abstract][Full Text] [Related]
15. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer. Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318 [TBL] [Abstract][Full Text] [Related]
16. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy. Sun Y; Zhang Y; Huang Z; Lin H; Lu X; Huang Y; Chi P World J Surg; 2020 Jun; 44(6):1975-1984. PubMed ID: 32020327 [TBL] [Abstract][Full Text] [Related]
17. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728 [TBL] [Abstract][Full Text] [Related]
18. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414 [TBL] [Abstract][Full Text] [Related]
19. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer. Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus. Toh E; Wilson J; Sebag-Montefiore D; Botterill I Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]